Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.69 |
| ▸ | RAB9A | P51151 | 4/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.69 |
| ▸ | CA12 | O43570 | 4/20 | 0.69 |
| ▸ | CA2 | P00918 | 4/20 | 0.69 |
| ▸ | CA9 | Q16790 | 4/20 | 0.69 |
| ▸ | POLB | P06746 | 3/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | F2 | P00734 | 3/20 | 0.64 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.64 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.64 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Orange SCHEMBL296471 | 1.00 | NPC1 (0.69) | NPC1RAB9AKMT2ACA12CA2 | |
| Methyl Orange SCHEMBL16163325 | 1.00 | NPC1 (0.69) | NPC1RAB9AKMT2ACA12CA2 | |
| Methyl Orange SCHEMBL19662 | 0.98 | NPC1 (0.67) | NPC1RAB9AKMT2ACA12CA2 | |
| SCHEMBL1134428 | 0.88 | ALDH1A1 (0.55) | NPC1RAB9AKMT2ACA12CA2 | |
| SCHEMBL27333040 | 0.86 | ALDH1A1 (0.53) | NPC1RAB9AKMT2ACA12CA2 | |
| Hydrochloric Acid SCHEMBL28095718 | 0.86 | ALDH1A1 (0.53) | NPC1RAB9AKMT2ACA12CA2 | |
| SCHEMBL30364928 | 0.86 | NPC1 (0.65) | NPC1RAB9AKMT2ACA12CA2 | |
| SCHEMBL9019333 | 0.85 | NPC1 (0.69) | NPC1RAB9AKMT2ACA12CA2 | |
| SCHEMBL15631068 | 0.85 | NPC1 (0.73) | NPC1RAB9AKMT2ACA12CA2 | |
| SCHEMBL29829178 | 0.85 | CA2 (0.51) | NPC1RAB9AKMT2ACA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1453 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746853-A1 | A LIPID DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2026-05-27 | — | — | EP | claimed |
| US-20260116796-A1 | METHOD FOR RAPIDLY STARTING DYE-ORGANIC WASTEWATER ANAEROBIC CO-METABOLIC SYSTEM BASED ON S-NZVI | NANJING UNIVERSITY (CN) | 2026-04-30 | — | — | US | claimed |
| US-12590308-B1 | Compositions and methods for suppressing intracellular synthesis of the beta subunit of human chorionic gonadotropin | James Summerton Living Trust dated May 15, 2008 (US) | 2026-03-31 | — | — | US | claimed |
| US-20260048382-A1 | HYPER-CROSS-LINKED POLYAMIDE/POLYAMINE 3D-NETWORK FOR WATER TREATMENT | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-02-19 | — | — | US | claimed |
| US-20250339517-A1 | LIPID NANOCARRIER VACCINE | MELBOURNE INST TECH (AU) | 2025-11-06 | — | — | US | claimed |
| WO-2025021835-A9 | A LIPID DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2025-11-06 | — | — | WO | claimed |
| WO-2025151305-A1 | MEMORY DEVICE WITH ENHANCED THERMAL CONDUCTIVITY | MICRON TECHNOLOGY, INC. (US) | 2025-07-17 | — | — | WO | claimed |
| US-20250233044-A1 | MEMORY DEVICE WITH ENHANCED THERMAL CONDUCTIVITY | MICRON TECHNOLOGY, INC. | 2025-07-17 | — | — | US | claimed |
| EP-4531812-A1 | LIPID NANOCARRIER VACCINE | Royal Melbourne Institute of Technology (AU) | 2025-04-09 | — | — | EP | claimed |
| CN-119546282-A | Lipid nanocarrier vaccine | 皇家墨尔本理工大学 | 2025-02-28 | — | — | CN | claimed |
| CN-114073982-A | Synthesis method of zinc oxide and perylene bisimide composite photocatalytic material with excellent photocatalytic performance under sunlight illumination | 新疆大学 | 2022-02-22 | — | — | CN | claimed |
| US-20220026773-A1 | MULTICOLOR, SINGLE ACTIVE LAYER ELECTROCHROMIC DEVICES | UNIVERSITY OF SOUTH FLORIDA (US) | 2022-01-27 | — | — | US | claimed |
| WO-2017161407-A1 | OXIDANT SENSOR | UNIVERSITY OF SOUTH AUSTRALIA (AU) | 2017-09-28 | — | — | WO | claimed |
| EP-0778023-B1 | Product comprising rapamycin or particular derivatives and an NMDA or AMPA antagonist for use for the treatment of epilepsy or Huntington's Disease, and the use of rapamycin or particular derivatives for the manufacture of a medicament for the treatment of epilepsy or Huntington's Disease. | WYETH CORP (US) | 2003-03-12 | — | — | EP | claimed |
| EP-1284828-A2 | PROCESS FOR COATING POLYMERIC SUBSTRATES AND RESULTANT COATINGS | 3M Innovative Properties Company (US) | 2003-02-26 | — | — | EP | claimed |
| US-6511701-B1 | Coatings and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2003-01-28 | — | — | US | claimed |
| WO-2001085361-A2 | PROCESS FOR COATING POLYMERIC SUBSTRATES AND RESULTANT COATINGS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-11-15 | — | — | WO | claimed |
| EP-0778023-A1 | Neuroprotective agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1997-06-11 | — | — | EP | claimed |
| US-5618726-A | DYE HAVING LIGNIN-LIKE SUBSTITUTION PATTERN AND A MICROBE CAPABLE OF PRODUCING EXTRACELLULAR PEROXIDASE | IDAHO RESEARCH FOUNDATION, INC. (US) | 1997-04-08 | — | — | US | claimed |
| WO-1992017550-A1 | BIODEGRADABLE AZO DYES | IDAHO RESEARCH FOUNDATION, INC. (US) | 1992-10-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590308-B1 | Compositions and methods for suppressing intracellular synthesis of the beta subunit of human chorionic gonadotropin | RNGTT, GNRHR, IGF2BP3 | NPC1 2523/4885RAB9A 4062/4885KMT2A 3895/4885 |
| US-20260116796-A1 | METHOD FOR RAPIDLY STARTING DYE-ORGANIC WASTEWATER ANAEROBIC CO-METABOLIC SYSTEM BASED ON S-NZVI | NDUFS6, SDHB, SORD | NPC1 3040/4885RAB9A 2362/4885KMT2A 3932/4885 |
| US-20260048382-A1 | HYPER-CROSS-LINKED POLYAMIDE/POLYAMINE 3D-NETWORK FOR WATER TREATMENT | H1-3, TET3, PAM | NPC1 4664/4885RAB9A 2033/4885KMT2A 19/4885 |
| US-20250339517-A1 | LIPID NANOCARRIER VACCINE | CD47, LY96, TSG101 | NPC1 68/4885RAB9A 757/4885KMT2A 3587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.